PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
11-Jun-2020 Anti-TNF therapies could treat patients with COVID-19-related acute respiratory distress, says GlobalData GlobalData Press Office
11-Jun-2020 LUNAC Therapeutics selects XenoGesis as strategic drug discovery partner XenoGesis Ltd
11-Jun-2020 VIVEbiotech collaborates with Xyphos Biosciences for clinical development support of convertibleCAR-T(TM) cell therapy Astellas Pharma Inc.
11-Jun-2020 NHS App Integrates eConsult for Online Consultations eConsult
11-Jun-2020 Fujifilm to invest 100 billion yen [807 million EUR] to expand its large scale biologics production facility in Denmark Fujifilm
11-Jun-2020 Herbert Smith Freehills advises Achilles Vaccines in record seed financing for biotech sector Herbert Smith Freehills
11-Jun-2020 Annual General Meeting Statement Ergomed plc
11-Jun-2020 Izana Bioscience’s drug namilumab announced in major UK COVID-19 drugs trial Izana Bioscience
11-Jun-2020 Vertex Announces European Commission Approval for KALYDECO® (ivacaftor) for Children and Adolescents With Cystic Fibrosis Between the Ages of 6 Months and 18 Years With the R117H Mutation in the CFTR Gene Vertex Pharmaceuticals Incorporated
11-Jun-2020 ICR and Cancer Research UK spinout company Monte Rosa Therapeutics launches with library of anti-cancer compounds Cancer Research UK
11-Jun-2020 Abbott Donates FreeStyle Libre Sensors for Hospitalised Patients with Diabetes in the UK During COVID-19 Pandemic Abbott
11-Jun-2020 RedHill Biopharma Submits COVID-19 Clinical Trial Application for Phase 2/3 Study with Opaganib RedHill Biopharma
11-Jun-2020 Genmab and AbbVie Announce Broad Oncology Collaboration Genmab
11-Jun-2020 Orgenesis announces anti-viral “BioShield” program designed to potentially increase preparedness, rapidly address virus spread and protect against future outbreaks such as COVID-19 Orgenesis
11-Jun-2020 ERT Acquires APDM Wearable Technologies to Reinvent Endpoint Measurement in Clinical Trials ERT
11-Jun-2020 Ashvattha Therapeutics Subsidiary Orpheris Announces Completion of Phase 1 Study of OP-101 Subcutaneous Formulation Ashvattha Therapeutics
11-Jun-2020 Sanofi to present growth opportunities and development strategy for Dupixent® (dupilumab) in type 2 inflammatory diseases Dupixent
11-Jun-2020 Investment Plan for Europe: European Investment Bank to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing The European Investment Bank
11-Jun-2020 Biophytis Receives MHRA Approval to Initiate the COVA Clinical Trial in the UK with Sarconeos (BIO101) for the Treatment of Patients with COVID-19 Related Respiratory Failure BIOPHYTIS
11-Jun-2020 Quell Therapeutics strengthens its Board with the appointments of Dr Dhaval Patel and Sir Robert Lechler and hires Dr Natalie Belmonte as SVP Research & Translation Quell Therapeutics